{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:36Z","timestamp":1788178416435,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.carrev.2026.08.015","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:28:59Z","timestamp":1787390939000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Balloon angioplasty for coronary artery disease: Best practices in the DCB era"],"prefix":"10.1016","author":[{"given":"Shreesh","family":"Kalagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo O.","family":"Escarcega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ragosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Vetrovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lipinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2026.08.015_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis","volume":"1","author":"Gruntzig","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.015_bb0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.015_bb0015","first-page":"1","article-title":"Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients","volume":"13","author":"Myler","year":"1987","journal-title":"Catheter Cardiovasc Diagn"},{"key":"10.1016\/j.carrev.2026.08.015_bb0020","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1093\/eurheartj\/ehaf029","article-title":"Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium","volume":"46","author":"Fezzi","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2026.08.015_bb0025","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jacc.2025.07.049","article-title":"Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement","volume":"86","author":"Fezzi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102779","article-title":"Drug-eluting balloons in calcified coronary lesions: a meta-analysis of clinical and angiographic outcomes","volume":"13","author":"Rivero-Santana","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.carrev.2026.08.015_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005935","article-title":"Clinical outcomes of drug-eluting balloon for in-stent restenosis based on the number of metallic layers","volume":"11","author":"Yabushita","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0040","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jcin.2015.04.032","article-title":"Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis","volume":"8","author":"Kawamoto","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.125.016289","article-title":"Predictors of target lesion failure in patients with in-stent restenosis: insights from the AGENT IDE trial","author":"Abbott","year":"2026","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0050","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.4244\/EIJ-D-24-00807","article-title":"Long-term clinical outcomes of intravascular brachytherapy for multilayer drug-eluting in-stent restenosis","volume":"21","author":"Tanner","year":"2025","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0055","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2026.08.015_bb0060","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.4244\/EIJ-D-19-00051","article-title":"A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis","volume":"16","author":"Hamm","year":"2020","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.carrev.2026.08.015_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2026.03.021","article-title":"Sirolimus-eluting balloon vs repeat drug-eluting stent or balloon angioplasty for coronary in-stent restenosis","volume":"88","author":"Cutlip","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcin.2024.12.024","article-title":"Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis: The SIBLINT-ISR Randomized Trial","volume":"18","author":"Liu","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurheartj\/ehad026","article-title":"Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial","volume":"44","author":"Giacoppo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2026.08.015_bb0080","first-page":"625","article-title":"Comparison of Sirolimus-Versus Paclitaxel-Coated Balloons in Coronary Artery Disease: One-Year Results of Two Real-World Prospective Registries","volume":"106","author":"Vlieger","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.125.015161","article-title":"Drug-eluting stent, drug-coated balloon, or plain old balloon angioplasty for in-stent coronary restenosis: insights from a mixed treatment comparison meta-analysis of randomized trials","volume":"18","author":"Maqsood","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0090","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.amjcard.2016.12.006","article-title":"Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)","volume":"119","author":"Alfonso","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101204","article-title":"A Meta-Analysis of 3-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small-Vessel Coronary Artery Disease","volume":"3","author":"Dobromir Angheluta","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0105","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/eurheartj\/ehaf002","article-title":"Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study","volume":"46","author":"Fezzi","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2026.08.015_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2024.08.067","article-title":"Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial","volume":"85","author":"Gao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0115","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0120","doi-asserted-by":"crossref","first-page":"e791","DOI":"10.4244\/EIJ-E-24-00019","article-title":"Drug-coated balloons for acute coronary syndromes","volume":"20","author":"Scheller","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082945","article-title":"Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial","volume":"388","author":"Gao","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2026.08.015_bb0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12933-025-02922-2","article-title":"Drug-coated balloons and diabetes: a review","volume":"24","author":"Frazzetto","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0135","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jcin.2021.06.025","article-title":"Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial","volume":"14","author":"Wohrle","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0140","first-page":"1423","article-title":"Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies","volume":"104","author":"Verdoia","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.015_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011569","article-title":"Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial","volume":"15","author":"Scheller","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2025.10.027","article-title":"Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial","volume":"87","author":"Tao","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2026.08.015_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCULATIONAHA.126.079033","article-title":"Sirolimus-eluting balloon with provisional stenting versus systematic drug-eluting stent implantation to treat de novo coronary lesions: a randomized, open-label, noninferiority trial","volume":"154","author":"Spaulding","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.015_bb0165","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/01.CIR.102.24.2938","article-title":"Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler. DESTINI Study Group (Doppler Endpoint STenting INternational Investigation)","volume":"102","author":"Di Mario","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.015_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s42155-019-0072-2","article-title":"Prolonged versus brief balloon inflation during arterial angioplasty for de novo atherosclerotic disease: a systematic review and meta-analysis","volume":"2","author":"Rockley","year":"2019","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.carrev.2026.08.015_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2024.12.015","article-title":"Predictors and Long-Term Prognostic Significance of Bailout Stenting During Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the Eastbourne Study","volume":"239","author":"Gurgoglione","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0180","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","article-title":"Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review","volume":"75","author":"Yerasi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s12928-026-01287-x","article-title":"Angiographic residual stenosis and clinical outcomes after elective drug-coated balloon angioplasty for de novo coronary lesions: a single center retrospective study","author":"Tamura","year":"2026","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.carrev.2026.08.015_bb0190","article-title":"Comparison of angiographic result and long-term outcome in patients with in-stent restenosis treated with cutting balloon or with scoring balloon angioplasty","volume":"36","author":"Leick","year":"2024","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0195","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jcin.2022.07.034","article-title":"Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions","volume":"15","author":"Rheude","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0200","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.4244\/EIJ-D-26-00426","article-title":"Intravascular lithotripsy in comparison to rotational atherectomy for calcified lesions: the ICARE OFDI randomised trial","volume":"22","author":"Honton","year":"2026","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0205","first-page":"1656","article-title":"Enhanced Drug Effect With Cutting Balloon Followed by Drug Coated Balloon in a Rabbit Model","volume":"105","author":"Shiozaki","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.23736\/S2724-5683.22.05989-0","article-title":"Which predilatation balloons provide the best lesion preparation prior to use of drug coated balloons in de-novo lesions? Results from the PREPARE study","volume":"71","author":"Basavarajaiah","year":"2023","journal-title":"Minerva Cardiol Angiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001204","article-title":"Performing percutaneous coronary interventions with predilatation using non-compliant balloons at high-pressure versus conventional semi-compliant balloons: insights from two randomised studies using optical coherence tomography","volume":"7","author":"Cuculi","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.carrev.2026.08.015_bb0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.carrev.2025.03.009","article-title":"Cutting balloon versus standard balloon for lesion preparation of drug-coated balloon treatment in de-novo coronary artery lesions: Rationale and design of the randomized NATURE trial","volume":"81","author":"Ono","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2026.08.015_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2026.107361","article-title":"Antiplatelet treatment after drug-coated balloon treatment: Review of the current evidence and future perspectives","volume":"296","author":"Cortese","year":"2026","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2026.08.015_bb0230","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.25270\/jic\/23.00007","article-title":"Incidence, treatment and outcomes of coronary artery dissection during percutaneous coronary intervention","volume":"35","author":"Page","year":"2023","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0235","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.85.3.1012","article-title":"Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging","volume":"85","author":"Honye","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.015_bb0240","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0002-9149(91)90236-E","article-title":"Intracoronary ultrasound evaluation of interventional technologies","volume":"68","author":"Davidson","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0245","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","article-title":"A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels","volume":"16","author":"Ninomiya","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.CIR.67.4.723","article-title":"Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry","volume":"67","author":"Dorros","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.015_bb0255","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0002-9149(91)90780-O","article-title":"Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty","volume":"68","author":"Huber","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0260","first-page":"193","article-title":"Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting","volume":"86","author":"Albertal","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2026.08.015_bb0265","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcin.2024.04.014","article-title":"Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty: The ULTIMATE III Trial","volume":"17","author":"Gao","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0270","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","article-title":"Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.015_bb0275","first-page":"730","article-title":"Prognostic Significance of Bailout Stenting for Residual Stenosis or Dissection Following Drug-Coated Balloon Angioplasty: A Sub-Analysis of the EASTBOURNE Study","volume":"106","author":"Gurgoglione","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0280","article-title":"Novel Stentless Strategy With Perfusion and Drug-Coated Balloons for Treating Acute Coronary Syndrome","volume":"3","author":"Fukuoka","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0285","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jcin.2013.10.027","article-title":"Successful treatment of spontaneous coronary artery dissection with cutting balloon angioplasty as evaluated with optical coherence tomography","volume":"7","author":"Yumoto","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0290","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4244\/EIJV14I13A245","article-title":"Natural history of spontaneous coronary artery dissection: to stent or not to stent?","volume":"14","author":"Saw","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.carrev.2025.09.001","article-title":"A pharmacokinetic comparison between three drug delivery devices in porcine coronary arteries","volume":"84","author":"Tanaka","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2026.08.015_bb0300","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4244\/EIJ-D-23-00849","article-title":"Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions","volume":"20","author":"Yamamoto","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0305","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.4244\/EIJ-D-23-01006","article-title":"Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions","volume":"20","author":"Lee","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.015_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1655201","article-title":"Safety aspects of de novo DCB-only PCI-a practical checklist and a simplified revised dissection classification","volume":"12","author":"Corballis","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.carrev.2026.08.015_bb0315","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1161\/01.CIR.95.8.2044","article-title":"Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: the CLOUT Pilot Trial. Clinical Outcomes With Ultrasound Trial (CLOUT) Investigators","volume":"95","author":"Stone","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.015_bb0320","first-page":"217","article-title":"Comparison of lumen area after PTCA by IVUS and QCA","volume":"Suppl 12","author":"Takazawa","year":"1997","journal-title":"Heart Vessel"},{"key":"10.1016\/j.carrev.2026.08.015_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcin.2025.11.021","article-title":"IVUS, OCT, or Angiography as Guidance for PCI in Complex Coronary Artery Lesions: Network Meta-Analysis of Randomized Controlled Trials","volume":"19","author":"Carvalho","year":"2026","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2026.134663","article-title":"Clinical outcomes of intravascular imaging-guided versus angiography-guided drug-coated balloon angioplasty for de novo coronary lesions","volume":"461","author":"Shin","year":"2026","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0335","first-page":"193","article-title":"Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions","volume":"88","author":"Shin","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0340","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12872-024-04413-w","article-title":"Prognostic implications of increased and final quantitative flow ratios in patients treated with drug-coated balloons physiological evaluation after DCB in de novo lesions","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2026.08.015_bb0345","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.015_bb0350","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2023.05.057","article-title":"Comparison of Drug-Coated Balloon and Drug-Eluting Stent for the Treatment of Small Vessel Disease (from the Dissolve SVD Randomized Trial)","volume":"211","author":"Liu","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0360","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.amjms.2017.07.005","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study","volume":"354","author":"Gobic","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.carrev.2026.08.015_bb0365","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13019-021-01525-8","article-title":"Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction","volume":"16","author":"Hao","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.carrev.2026.08.015_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2016.07.156","article-title":"Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease","volume":"222","author":"Nishiyama","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2026.08.015_bb0375","first-page":"33","article-title":"Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study","volume":"101","author":"Qian","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0380","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study","volume":"96","author":"Cortese","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2026.08.015_bb0385","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0390","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0395","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.08.015_bb0400","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacasi.2024.10.028","article-title":"A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease","volume":"5","author":"Shin","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.carrev.2026.08.015_bb0405","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10557-021-07172-4","article-title":"A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions","volume":"36","author":"Yu","year":"2022","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892600374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892600374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:14:26Z","timestamp":1788174866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383892600374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"alternative-id":["S155383892600374X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2026.08.015","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balloon angioplasty for coronary artery disease: Best practices in the DCB era","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2026.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}